Dr. Reddy’s enters hormone replacement therapy market
pre-market1 source ↓written by the desknot a recommendation
Dr. Reddy’s Laboratories has acquired trademarks for Progynova and Cyclo-Progynova from Mercury Pharma Group, enhancing its gynaecology portfolio. Progynova, with sales of ₹100 cr, is a leading brand in the oral HRT market. This acquisition marks a strategic entry into the hormone replacement therapy segment, potentially boosting market presence.
Not investment advice. For informational purposes only.